Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Histone Deacetylase Inhibitors Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of cancer coupled with need for effective treatment therapies
5.1.1.2. Increasing application in prognosis, treatment and diagnosis of chronic diseases
5.1.1.3. Rising need from psychiatry and neurology attributed to their mood stabilizing and anti-epileptic properties
5.1.2. Restraints
5.1.2.1. Dearth of awareness among people and lack of reimbursement policies
5.1.2.2. High cost of raw material and lack of trained professionals
5.1.3. Opportunities
5.1.3.1. Rising adoption of advanced technologies and collaboration among manufacturers and companies
5.1.3.2. Increasing investment for drug development from government and private organizations
5.1.4. Challenges
5.1.4.1. Strict mandates for the production and probable side effects such as toxicity
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Histone Deacetylase Inhibitors Market, by Class
6.1. Introduction
6.2. Class I HDACs
6.3. Class II HDACs
6.4. Class III HDACs

7. Histone Deacetylase Inhibitors Market, by Application
7.1. Introduction
7.2. Central Nervous System Disorders
7.3. Neurology
7.4. Oncology

8. Americas Histone Deacetylase Inhibitors Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Histone Deacetylase Inhibitors Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Histone Deacetylase Inhibitors Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AstraZeneca PLC
12.1.2. Bristol Myers Squibb Company
12.1.3. Celleron Therapeutics Ltd.
12.1.4. Eisai Co., Ltd.
12.1.5. Karyopharm Therapeutics Inc.
12.1.6. MEI Pharma Inc.
12.1.7. Merck KGaA
12.1.8. Midatech Pharma PLC
12.1.9. Novartis AG
12.1.10. Oncolys BioPharma Inc.
12.1.11. Regenacy Pharmaceuticals, Inc.
12.1.12. Shenzhen Chipscreen Biosciences Co., Ltd.
12.1.13. Spectrum Pharmaceuticals, Inc.
12.1.14. Syndax Pharmaceuticals, Inc.
12.1.15. Tokyo Chemical Industry Co. , Ltd.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. HISTONE DEACETYLASE INHIBITORS MARKET RESEARCH PROCESS
FIGURE 2. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, 2023 VS 2030
FIGURE 3. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HISTONE DEACETYLASE INHIBITORS MARKET DYNAMICS
FIGURE 7. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2023 VS 2030 (%)
FIGURE 8. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. HISTONE DEACETYLASE INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. HISTONE DEACETYLASE INHIBITORS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. HISTONE DEACETYLASE INHIBITORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 6. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS I HDACS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS II HDACS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS III HDACS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. CANADA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 21. CANADA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. MEXICO HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 23. MEXICO HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. CHINA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 33. CHINA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. INDIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 35. INDIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. JAPAN HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 39. JAPAN HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. THAILAND HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 51. THAILAND HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 58. DENMARK HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. EGYPT HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 60. EGYPT HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. FINLAND HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 62. FINLAND HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. FRANCE HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 64. FRANCE HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. GERMANY HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 66. GERMANY HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. ITALY HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 70. ITALY HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. NORWAY HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 76. NORWAY HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. POLAND HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 78. POLAND HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. QATAR HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 80. QATAR HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SPAIN HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 88. SPAIN HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. TURKEY HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 94. TURKEY HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM HISTONE DEACETYLASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. HISTONE DEACETYLASE INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 100. HISTONE DEACETYLASE INHIBITORS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 101. HISTONE DEACETYLASE INHIBITORS MARKET LICENSE & PRICING